sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Blood Stream Infection Testing Market by Product (Instruments, Consumables, Software and Services), by Technique (Conventional, Automated), by Technology (Culture-based, Molecular, Proteomic), by Application (Bacterial, Fungal, Mycobacterial), by End-users (Hospitals, Independent Diagnostics Centers, Others): Global Opportunity Analysis and Industry Forecast, 2022-2030

Blood Stream Infection Testing Market by Product (Instruments, Consumables, Software...

Home / Categories / Healthcare
Blood Stream Infection Testing Market by Product (Instruments, Consumables, Software and Services), by Technique (Conventional, Automated), by Technology (Culture-based, Molecular, Proteomic), by Application (Bacterial, Fungal, Mycobacterial), by End-users (Hospitals, Independent Diagnostics Centers, Others): Global Opportunity Analysis and Industry Forecast, 2022-2030
Blood Stream Infection Testing Market...
Report Code
RO14/128/2870

Publish Date
23/Jan/2023

Pages
200
PRICE
$ 4900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5400/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8700/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
The global bloodstream infection testing market size was US$ 5.1 billion in 2021. The global bloodstream infection testing market size is estimated to reach US$ 12.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period from 2022 to 2030.
Any bacterial, fungal, or any other type of infection found in the blood is known as a bloodstream infection. Once the pathogen enters the bloodstream of any part of the body, the disease becomes apparent as it starts spreading the infection in the body. Bloodstream infection tests are used to identify bacteria or other organisms that cause blood infections.
Densely populated areas are a major threat to human health due to very poor sanitation, which promotes the spread of many infectious diseases. Bloodstream infections are challenging to self-diagnose because of the wide spectrum of symptoms such as chills, chills, fever, diarrhea, and vomiting.

Factors Affecting Marketing Growth

A rise in the number of bloodstream infections globally is expected to drive the growth of the global market.
The need for rapid diagnosis and recent advancements in bloodstream infection testing is expected to boost the growth of the global market.
The rising incidences of bloodstream infection in the elderly population who are susceptible to infection due to low immunity is expected to drive the growth of the global market.
The lack of insurance and reimbursement policies is also projected to hinder the growth of the global market.

Impact on COVID-19 Analysis

The COVID-19 outbreak caused a global public health emergency and brought the world to a halt, affecting every other sector in 2020. Strict lockdown and government limitations had impacted negatively the growth of the global bloodstream infection testing market.

Regional Analysis

North America held the leading share in 2021 in the global bloodstream infection testing market. The rise in the geriatric population and the existence of a large number of healthcare facilities across the region is predicted to be the major factor for the revenue growth of the global bloodstream infection testing market in the region.

Leading Competitors
The prominent players in the global bloodstream infection testing market are:
Bruker Corporation
Accelerate Diagnostics Inc
AdvanDx
Luminex Corporation
BioMrieux SA
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Cepheid
Suzhou
Others
Segmentation Analysis
The global bloodstream infection testing market segmentation focuses on Technology, Product, Technique, Application, End User, and Region.
Segmentation on the basis of Technology
Culture-based
Molecular
Proteomic

Segmentation on the basis of Product
Instruments
Consumables
Software and Services

Segmentation on the basis of Technique
Conventional
Automated

Segmentation on the basis of Application
Bacterial
Fungal
Mycobacterial

Segmentation on the basis of End User
Hospitals
Independent Diagnostics Centers
Others

Segmentation on the basis of Region
North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com